AbbVie Inc Stock Performance
as on June 6, 2026 at 6:59 am IST
Day's Low
Day's High
$226.00$230.47
0.56%
Downside
1.41%
Upside
52 Week's Low
52 Week's High
$181.73$244.8120.04%
Downside
7.72%
Upside
AbbVie Inc share price movements today
- Previous Close
- $224.94
- Open
- $226.91
- Volume
- 4.4M
- Day's Low - High
- $226.00 - $230.47
- 52 Week Low - High
- $181.73 - $244.81
AbbVie Inc Historical Returns
- 1 Month Return
- + 9.14 %
- 3 Month Return
- -3.19 %
- 1 Year Return
- + 19.99 %
- 3 Year Return
- + 64.36 %
- 5 Year Return
- + 100.2 %
AbbVie Inc Stock Fundamentals & Key Indicators
Check AbbVie Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$383.6B
EPS (TTM)
14.2374
Dividend Yield
3.13%
Quarterly Earnings Growth YOY
-0.46%
PE Ratio (TTM)
106.44
Industry PE ratio
24.844285714285714
PEG Ratio
0.5869
EBITDA
29.9B
Revenue (TTM)
62.8B
Profit Margin
5.79%
Return On Equity TTM
62.25%
AbbVie Inc Stock Valuation
Track how AbbVie Inc P/E has moved over time to understand its valuation trends.
AbbVie Inc in the last 5 years
Lowest (9.28x)
September 30, 2021
Industry (24.84x)
June 5, 2026
Today (106.44x)
June 5, 2026
Highest (22.78x)
December 31, 2025
Today’s Price to Earnings Ratio: 106.44x
AbbVie Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of AbbVie Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $383.6B | 100.2% | 106.44 | 5.79% | 3.1300000000000003% | |
| BUY | $962.0B | 457.01% | 38.25 | 34.99% | 0.59% | |
| BUY | $273.4B | 220.07% | 26.51 | 17.19% | 1.7999999999999998% | |
| BUY | $537.4B | 37.48% | 25.84 | 21.83% | 2.33% | |
| BUY | $283.3B | 62.27% | 32.22 | 13.59% | 2.8400000000000003% |
Stock Returns calculator for AbbVie Inc Stock including INR - Dollar returns
The AbbVie Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
AbbVie Inc investment value today
Current value as on today
₹1,34,083
Returns
₹34,083
(+34.08%)
Returns from AbbVie Inc Stock
₹21,230 (+21.23%)
Dollar Impact
₹12,852 (+12.85%)
Analyst Recommendation on AbbVie Inc Stock
Based on 35 analysts
65.71%
Buy
34.29%
Hold
0.00%
Sell
Based on 35 analysts, 65.71% of analysts recommend a 'BUY' rating for AbbVie Inc. Average target price of $252.9
AbbVie Inc Share Price Target
Get share price movements and forecasts by analysts on AbbVie Inc.
What analysts predicted
10.13%UPSIDE
Target Price
$252.9
Current Price
$227.27
Analyzed by
35 Analysts
Target
$252.90
AbbVie Inc target price $252.9, a slight upside of 10.13% compared to current price of $227.27. According to 35 analysts rating.
Indian Investors' Interest in AbbVie Inc Stock
Investment in AbbVie Inc Shares on INDmoney has dropped by -7.18% in the last 30 days, indicating reduced investment activity.
Time period: to
Search interest for AbbVie Inc Stock has increased by 135% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:135%Â versus previous 30 day period
AbbVie Inc Quarterly Profit & Loss
All numbers in Millions USD
AbbVie Inc Annual Profit & Loss
All numbers in Millions USD
AbbVie Inc Quarterly Cash Flow
All numbers in Millions USD
AbbVie Inc Annual Cash Flow
All numbers in Millions USD
Mutual Funds that own AbbVie Inc Stock
Check out the Mutual Funds with significant holdings in AbbVie Inc.
Funds | Holdings | Shares Held |
|---|---|---|
 Motilal Oswal S&P 500 Index Fund Direct Growth | 0.60149% | 13091 |
 Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth | 2.81159% | 2397 |
Global Institutional Holdings in AbbVie Inc
AbbVie Inc News & Key Events
Today's Timeline - 03 June
Wed, 04:06 PM
-AbbVie receives EC approval for Aquipta, an acute migraine treatment, marking its second indication in the EU.
Wed, 07:33 PM
-AbbVie announces EU approval for Aquipta, highlighting strong sales growth in its neuroscience portfolio.
Wed, 09:36 PM
-AbbVie reports 400% returns over 10 years, despite Humira sales decline and patent cliff concerns.
Insights on AbbVie Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, ABBV stock has moved up by 3.3%
NO EFFECTAgainst Peers
In the last 3 years, Eli Lilly & Co. has given 148.4% return, outperforming this stock by 84.0%
- NO EFFECT
Against Peers
In the last 1 year, AstraZeneca PLC has given 151.3% return, outperforming this stock by 131.3%
NEGATIVE IMPACTProfit Down
AbbVie Inc. has experienced a decline in net profit over the last two quarters. The company's net profit dropped from $1.81 billion to $699 million, reflecting an average decrease of 61.5% each quarter.
- NEGATIVE IMPACT
Revenue Fall
AbbVie Inc. has experienced a decline in revenue for the past two quarters. Revenue decreased from $16.61 billion to $15.00 billion, resulting in an average decrease of 9.7% per quarter.
About AbbVie Inc
| Organisation | AbbVie Inc |
| Headquarters | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 |
| Industry | Drug Manufacturers - General |
| CEO | Mr. Robert A. Michael CPA |
| E-voting on shares | Click here to vote |
Key Management of AbbVie Inc
Name | Title |
|---|---|
Dr. Roopal B. Thakkar M.D. | Executive VP of Research & Development and Chief Scientific Officer |
Mr. Jeffrey Ryan Stewart | Executive VP & Chief Commercial Officer |
Ms. Linda Ray | Senior VP & Chief Information Officer |
Ms. Elizabeth Shea | Senior Vice President of Investor Relations |
Mr. Demetris D. Crum | Executive VP & Chief Human Resources Officer |
Mr. Scott T. Reents | Executive VP & CFO |
Dr. Azita Saleki-Gerhardt Ph.D. | Executive VP & COO |
Mr. Perry C. Siatis | Executive VP, General Counsel & Secretary |
Mr. Wulff-Erik von Borcke | Senior VP & President of Oncology |
Mr. Robert A. Michael CPA | CEO & Chairman of the Board |
FAQs
What is AbbVie Inc share price today?
AbbVie Inc share price today is $227.27 as on at the close of the market. AbbVie Inc share today touched a day high of $230.47 and a low of $226.
What is the 52 week high and 52 week low for AbbVie Inc share?
AbbVie Inc share touched a 52 week high of $244.81 on and a 52 week low of $181.73 on . AbbVie Inc stock price today i.e. is closed at $227.27,which is 7.16% down from its 52 week high and 25.06% up from its 52 week low.
What is AbbVie Inc's market capitalisation today?
AbbVie Inc market capitalisation is $0.38T as on .
How to invest in AbbVie Inc Stock (ABBV) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for AbbVie Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in AbbVie Inc Shares that will get you 0.0066 shares as per AbbVie Inc share price of $227.27 per share as on June 6, 2026 at 1:29 am IST.
What is the minimum amount required to buy AbbVie Inc Stock (ABBV) from India?
Indian investors can start investing in AbbVie Inc (ABBV) shares with as little as ₹94.935 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.35 in AbbVie Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on AbbVie Inc share’s latest price of $227.27 as on June 6, 2026 at 1:29 am IST, you will get 0.0440 shares of AbbVie Inc. Learn more about
fractional shares .
What are the returns that AbbVie Inc has given to Indian investors in the last 5 years?
AbbVie Inc stock has given 100.2% share price returns and 30.84% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?